Patheon Appoints Terence S. Novak as President, North American Operations and Chief Marketing Officer

    TORONTO, Feb. 14 /CNW/ - Patheon Inc. (TSX: PTI) today announced that it
has appointed Terry Novak as President, North American Operations and Chief
Marketing Officer, effective February 18, 2008. Mr. Novak will be responsible
for managing and growing Patheon's North American network of commercial
manufacturing operations, which includes three plants in Canada, three in
Puerto Rico and one in Cincinnati. Two of the Company's North American sites,
York Mills and Carolina, will be sold as part of a previously announced
rationalization program, leaving a network of five sites in North America.
    Mr. Novak has more than 28 years of pharmaceutical industry experience,
including senior commercial management positions at Bristol-Myers Squibb,
Quintiles and Cytogen. Most recently, Mr. Novak was President of DSM
Pharmaceuticals Inc., the contract manufacturing business arm of Netherlands-
based Royal DSM, N.V. Mr. Novak is a highly regarded speaker at industry
conferences and also serves on the Editorial Advisory Board of Contract Pharma
magazine and the North Carolina Biotechnology Advisory Board. Mr. Novak holds
a Bachelors of Science in Biology from Muhlenberg College.
    "We are extremely privileged to have Terry as a new member of our
executive management team," said Wesley P. Wheeler, Chief Executive Officer,
Patheon Inc. "Terry has a unique perspective on the pharmaceutical
manufacturing outsourcing market and has a demonstrated track record of
success in this business."

    Caution Concerning Forward-Looking Statements

    This news release contains forward-looking statements which reflect
management's expectations regarding the Company's future growth of operations,
performance (both operational and financial) and business prospects and
opportunities. These statements are made in the context of the risks and
uncertainties that are outlined in the Company's public documents, which can
be accessed on our website at

    Patheon (TSX:PTI; is a leading global provider of drug
development and manufacturing services to the international pharmaceutical
industry. Patheon operates a network of 12 facilities in the United States,
Canada and Europe, employing more than 4,650 people and serving a client base
of more than 250 pharmaceutical and biotechnology companies.

    %SEDAR: 00001700E

For further information:

For further information: Mr. Wesley P. Wheeler, Chief Executive Officer,
Patheon Inc., Tel: (905) 812-2112, Fax: (905) 812-6613, Email:; Ms. Shelley Jourard, Director, Corporate
Communications, Tel: (905) 812-6614, Fax: (905) 812-6613, Email:

Organization Profile

Patheon Inc

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890